Default object view. Click to create a custom template, Node ID: 73515, Object ID: 45715

A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neck

A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neck

No relation

Yes

No relation

No

13/06/2014 9:28 am

No